Piraino F, Costa M, Meyer M, Cornish G, Ceroni C, Garnier V, Hoehnel-Ka S, Brandenberg N (2024) Organoid models: the future companions of personalized drug development
A new rule that went into effect in May 2025 could help make this happen by creating an additional condition for nonprescription use protocol, which means that a person may need to consult with a pharmacist or answer questions on an automated telephone system or an app before being allowed to purchase a medication
The benefits of GLP-1 extend beyond weight loss, which can include significant reductionsoften 15-20% of body weightover months
*Results measured in participants who adhered to the dosing schedule and reached the maximum dose of semaglutide
This product is not intended for human consumption, medical use, therapeutic treatment, disease prevention, or diagnostic applications